Minimal Residual Diseases (MRD): Hematology Journal Club 2

Back to Video Library

Hey there, great course, right? Do you like this course?

All of the most interesting lessons further. In order to continue you just need to purchase it

Enroll course

Session sections

Section 1

Confirmatory Phase II of Blinatumomab(MT103) In Patients with Minimal Residual Disease of B-Precursor ALL

Case Presentation ( MRD+ Case) From Mediclinic Hospital

Cytokine Release Syndrome in Patients Receiving Therapy for Acute Lymphoblastic Leukemia

Hematology Journal Club 2.0: Panel Discussion

Case Presentation ( MRD+ Case) From Mediclinic Hospital

Lesson is locked. Please Buy course to proceed.

Confirmatory Phase II of Blinatumomab(MT103) In Patients with Minimal Residual Disease of B-Precursor ALL

Cytokine Release Syndrome in Patients Receiving Therapy for Acute Lymphoblastic Leukemia